<qa>  What is the name of the study drug that is associated with significant cardiovascular impairment?8. Significant cardiovascular impairment: History of a congestive heart failure greater than New York Heart Association NYHA Class II, b unstable angina, c myocardial infarction, d stroke, or e cardiac arrhythmia associated with impairment within 6 months of the first dose of study drug. 